FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011620007> ?p ?o ?g. }

• W2011620007 endingPage "1065" @default.
• W2011620007 startingPage "1054" @default.
• W2011620007 abstract "Increased hypercoagulability has been reported with low doses of direct thrombin inhibitors but not with direct factor Xa inhibitors.To compare the effects of rivaroxaban with those of melagatran and dabigatran on thrombin generation (TG) and tissue factor-induced hypercoagulability and to explore the possible involvement of the thrombin-thrombomodulin/activated protein C system.In normal human plasma and in protein C-deficient plasma, TG was investigated in vitro in the presence and absence of recombinant human soluble thrombomodulin (rhs-TM). TG was determined by calibrated automated thrombography and an ELISA for prothrombin fragments 1+2 (F1+2 ). In an in vivo rat model, hypercoagulability was induced by tissue factor; levels of thrombin-antithrombin (TAT) and fibrinogen and the platelet count were determined.Rivaroxaban inhibited TG in a concentration-dependent manner. In the absence of rhs-TM, melagatran and dabigatran also inhibited TG concentration dependently. However, in the presence of rhs-TM, lower concentrations of melagatran (119-474 nmol L(-1) ) and dabigatran (68-545 nmol L(-1) ) enhanced endogenous thrombin potential, peak TG, and F1+2 formation in normal plasma but not in protein C-deficient plasma. In vivo, rivaroxaban dose-dependently inhibited TAT generation, whereas melagatran showed a paradoxical effect, with an increase in TAT and a small decrease in fibrinogen and platelet count at lower doses.Low concentrations of the direct thrombin inhibitors melagatran and dabigatran enhanced TG and hypercoagulability, possibly via inhibition of the protein C system. In contrast, rivaroxaban reduced TG and hypercoagulability under all conditions studied, suggesting that it does not suppress this negative-feedback system." @default.
• W2011620007 created "2016-06-24" @default.
• W2011620007 creator A5011603361 @default.
• W2011620007 creator A5022961697 @default.
• W2011620007 creator A5045257458 @default.
• W2011620007 creator A5062695817 @default.
• W2011620007 date "2014-07-01" @default.
• W2011620007 modified "2023-10-11" @default.
• W2011620007 title "Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor‐induced hypercoagulability in vitro and in vivo" @default.
• W2011620007 cites W1489399279 @default.
• W2011620007 cites W1532321223 @default.
• W2011620007 cites W1738640266 @default.
• W2011620007 cites W1965306847 @default.
• W2011620007 cites W1977494658 @default.
• W2011620007 cites W1981340953 @default.
• W2011620007 cites W2000343579 @default.
• W2011620007 cites W2023523876 @default.
• W2011620007 cites W2040258974 @default.
• W2011620007 cites W2046584245 @default.
• W2011620007 cites W2047652079 @default.
• W2011620007 cites W2054673016 @default.
• W2011620007 cites W2056894234 @default.
• W2011620007 cites W2057308876 @default.
• W2011620007 cites W2064826963 @default.
• W2011620007 cites W2094389532 @default.
• W2011620007 cites W2112378432 @default.
• W2011620007 cites W2113141624 @default.
• W2011620007 cites W2119078920 @default.
• W2011620007 cites W2119768870 @default.
• W2011620007 cites W2128428354 @default.
• W2011620007 cites W2134359334 @default.
• W2011620007 cites W2139511461 @default.
• W2011620007 cites W2161876144 @default.
• W2011620007 cites W2163665005 @default.
• W2011620007 doi "https://doi.org/10.1111/jth.12591" @default.
• W2011620007 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4285304" @default.
• W2011620007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24766850" @default.
• W2011620007 hasPublicationYear "2014" @default.
• W2011620007 type Work @default.
• W2011620007 sameAs 2011620007 @default.
• W2011620007 citedByCount "53" @default.
• W2011620007 countsByYear W20116200072014 @default.
• W2011620007 countsByYear W20116200072015 @default.
• W2011620007 countsByYear W20116200072016 @default.
• W2011620007 countsByYear W20116200072017 @default.
• W2011620007 countsByYear W20116200072018 @default.
• W2011620007 countsByYear W20116200072019 @default.
• W2011620007 countsByYear W20116200072020 @default.
• W2011620007 countsByYear W20116200072021 @default.
• W2011620007 countsByYear W20116200072022 @default.
• W2011620007 countsByYear W20116200072023 @default.
• W2011620007 crossrefType "journal-article" @default.
• W2011620007 hasAuthorship W2011620007A5011603361 @default.
• W2011620007 hasAuthorship W2011620007A5022961697 @default.
• W2011620007 hasAuthorship W2011620007A5045257458 @default.
• W2011620007 hasAuthorship W2011620007A5062695817 @default.
• W2011620007 hasBestOaLocation W20116200071 @default.
• W2011620007 hasConcept C126322002 @default.
• W2011620007 hasConcept C150903083 @default.
• W2011620007 hasConcept C185592680 @default.
• W2011620007 hasConcept C186738567 @default.
• W2011620007 hasConcept C201267052 @default.
• W2011620007 hasConcept C207001950 @default.
• W2011620007 hasConcept C2776301958 @default.
• W2011620007 hasConcept C2776710957 @default.
• W2011620007 hasConcept C2777151630 @default.
• W2011620007 hasConcept C2777292125 @default.
• W2011620007 hasConcept C2777557582 @default.
• W2011620007 hasConcept C2778382381 @default.
• W2011620007 hasConcept C2778661090 @default.
• W2011620007 hasConcept C2778810321 @default.
• W2011620007 hasConcept C2779026020 @default.
• W2011620007 hasConcept C2779036427 @default.
• W2011620007 hasConcept C2779161974 @default.
• W2011620007 hasConcept C2781287897 @default.
• W2011620007 hasConcept C55493867 @default.
• W2011620007 hasConcept C57002609 @default.
• W2011620007 hasConcept C71924100 @default.
• W2011620007 hasConcept C86803240 @default.
• W2011620007 hasConcept C89560881 @default.
• W2011620007 hasConcept C98274493 @default.
• W2011620007 hasConceptScore W2011620007C126322002 @default.
• W2011620007 hasConceptScore W2011620007C150903083 @default.
• W2011620007 hasConceptScore W2011620007C185592680 @default.
• W2011620007 hasConceptScore W2011620007C186738567 @default.
• W2011620007 hasConceptScore W2011620007C201267052 @default.
• W2011620007 hasConceptScore W2011620007C207001950 @default.
• W2011620007 hasConceptScore W2011620007C2776301958 @default.
• W2011620007 hasConceptScore W2011620007C2776710957 @default.
• W2011620007 hasConceptScore W2011620007C2777151630 @default.
• W2011620007 hasConceptScore W2011620007C2777292125 @default.
• W2011620007 hasConceptScore W2011620007C2777557582 @default.
• W2011620007 hasConceptScore W2011620007C2778382381 @default.
• W2011620007 hasConceptScore W2011620007C2778661090 @default.
• W2011620007 hasConceptScore W2011620007C2778810321 @default.
• W2011620007 hasConceptScore W2011620007C2779026020 @default.
• W2011620007 hasConceptScore W2011620007C2779036427 @default.
• W2011620007 hasConceptScore W2011620007C2779161974 @default.

• next